HIGHLIGHTS
- who: Ting-Ting Yang from the University of Texas MD Anderson Cancer Center, United States have published the research work: Comparable outcomes in patients with B-cell acute lymphoblastic leukemia receiving haploidentical hematopoietic stem cell transplantation: Pretransplant minimal residual disease-negative complete remission following chimeric antigen receptor T-cell thera, in the Journal: (JOURNAL)
- what: The authors aimed to analyze transplantation outcomes after haploidentical HSCT (haplo-HSCT) in R/R patients with MRD - CR from CAR-T therapy, choosing patients who received haplo-HSCT after MRD - CR postchemotherapy over the same period as a control . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.